XPeng Vs. NIO: Can Tech, Trend Turn The Tables Ahead Of Q3 Earnings? – XPeng (NYSE:XPEV), NIO (NYSE:NIO) November 18, 2024
Carisma Therapeutics Presents Promising New Preclinical Data on Engineered Macrophages for the Treatment of Liver Fibrosis at AASLD The Liver Meeting® 2024 – CARISMA Therapeutics (NASDAQ:CARM) November 18, 2024